In this report, we identified three of these proteins: Shc, a signaling protein that couples membrane tyrosine kinases with Ras; p62, a protein which can bind to p2l"GAP; and heterogeneous nuclear ribonucleoprotein K, a pre-mRNA-binding protein. All of these proteins contain proline-rich peptide motifs that could serve as SH3 domain ligands, and the binding of these proteins to the Src SH3 domain was inhibited with a proline-rich Src SH3 peptide ligand. These three proteins, as well as most of the other Src SH3 ligands, also bound to the SH3 domains of the closely related protein tyrosine kinases Fyn and Lyn. However, Src-and Lyn-specific SH3-binding proteins were also detected, suggesting subtle differences in the binding specificity of the SH3 domains from these related proteins. Several Src SH3-binding proteins were phosphorylated in Src-transformed cells. The phosphorylation of these proteins was not detected in cells transformed by a mutant variant of Src lacking the SH3 domain, while there was little change in tyrosine phosphorylation of other Src-induced phosphoproteins. In addition, the coprecipitation of v-Src with two tyrosyl-phosphorylated proteins with Mrs of 62,000 and 130,000 was inhibited by incubation with a Src S13 peptide ligand, suggesting that the binding of these substrate proteins is dependent on interactions with the SH3 domain. These results strongly suggest a role for the Src SH3 domain in the recruitment of substrates to this protein tyrosine kinase, either through direct interaction with the SH3 domain or indirectly through interactions with proteins that bind to the SH3 domain.
is dependent on interactions with the SH3 domain. These results strongly suggest a role for the Src SH3 domain in the recruitment of substrates to this protein tyrosine kinase, either through direct interaction with the SH3 domain or indirectly through interactions with proteins that bind to the SH3 domain.
The Src family of protein tyrosine kinases contains two conserved domains, the Src homology 2 (SH2) and Src homology 3 (SH3) domains. SH2 and SH3 domains mediate intramolecular and intermolecular binding interactions which regulate the functional activity of these proteins in intracellular signal transduction pathways (20, 37, 38) . The intermolecular protein-protein interactions couple Src family kinases with proteins which serve as protein substrates or which determine the subcellular localization of these enzymes (5, 20) . The intramolecular binding interactions mediated by SH2 and SH3 domains regulate the catalytic activity of these kinases (20, 50, 56) . SH2 and SH3 domains are also found in other protein tyrosine kinases (e.g., Abl, Fps, Syk, and Zap) as well as in cellular proteins otherwise unrelated to Src family kinases (38) . These proteins include enzymes (e.g., phospholipase C--y, p21aSGAP [a Ras GTPase-activating protein], and the p85 subunit of phosphatidylinositol 3'-kinase [p85-PI-3K]), transcription factors (e.g., the p113, p91, and p84 subunits of interferon-stimulated gene factor 3), cytoskeletal proteins (e.g., tensin, cortactin, myosin 1B, and a-spectrin), and adaptor proteins that appear to serve exclusively as coupling factors that link proteins involved in signaling pathways (e.g., Grb-2/ Sem5, Nck, and Crk) (6, 8, 14, 20, 28, 31, 37, 38) . While SH2 these substrates close to Src where they can be phosphorylated by the catalytic domain. SH3 interactions may also affect the catalytic activity of interacting proteins as proposed for PI-3K (27) and as shown for the GTPase activity of dynamin (17) .
We previously established solution-binding conditions that allow affinity isolation of Src SH3-binding proteins in cellular extracts (60) . Multiple proteins were isolated from Tritoninsoluble cell fractions, and several of these proteins were phosphorylated on tyrosine in Src-transformed cells. One of these proteins was identified as the cytoskeletal protein substrate paxillin. In this report, we identify three additional Src SH3-binding proteins (Shc, p62 , and heterogeneous nuclear ribonucleoprotein [hnRNP] K) and show that the profile of Src SH3-binding proteins is similar but not identical to that of Lyn and Fyn SH3 domains. In addition, we show that the major Src SH3-binding proteins are not phosphorylated in cells transformed by a Src SH3 deletion mutant and that Src SH3-binding peptides interfere with the binding of v-Src to at least two major tyrosyl-phosphorylated proteins that coprecipitated with v-Src from transformed cell extracts. These results provide further characterization of SH3 binding interactions of Src family kinases and strongly implicate the SH3 domain in the recruitment of substrates to these kinases.
MATERILLS AND METHODS
Generation of recombinant pGEX-2T plasmids. The pGEX-2T vector was kindly provided by B. Wu (Northwestern University) (54) . Sequences coding for the SH3 domains of chicken c-Src (representing amino acids 81 to 147), human c-Fyn (representing amino acids 82 to 148) (51) , and human c-Lyn (representing amino acids 62 to 128) (62) were amplified by PCR from the corresponding cDNAs and cloned into the pGEX-2T vector at the BamHI site. Two Src SH3 variants, a chicken neuronal c-Src' SH3 (containing a six-amino-acid insertion at amino acid 114 produced by alternative splicing [25, 46] ) and a Src SH3 deletion mutant (d190-92) were also derived by PCR amplification and cloned into the BamHI site. Sequences coding for the SH2 domain of chicken c-Src (representing amino acids 144 to 251) and the full-length human hnRNP K (amino acids 1 to 463) were amplified by PCR and cloned into the EcoRI site of pGEX-2T vector. To generate hnRNP K containing a deletion of the putative SH3-binding site, two PCR fragments (encoding amino acids 1 to 283 and 321 to 463, respectively) were ligated into the EcoRI site of pGEX-2T vector. The resulting cDNA lacked codons 284 to 320 of hnRNP K and contained two exogenous codons as a result of the XhoI linker site. Sequences coding for the putative SH3-binding domain (amino acids 284 to 320) in hnRNP K were also amplified by PCR and cloned into the BamHI-EcoRI site of pGEX-2T vector. The recombinant plasmids were subjected to double-stranded DNA sequencing to check for orientation and sequence integrity of the insertion.
Preparation and purification of GST and fusion proteins.
GST and GST-SH3 fusion proteins were generated as previously described, with some modifications (24, 60 and Src+]. Figure 1 shows the purified GST-SH3 fusion proteins, and Fig. 2 shows the proteins from [35S]methionine-labeled SRD 3T3 cell lysates that were affinity purified by using the GST-SH3 fusion VOL. 14, 1994 on January 11, 2018 by guest proteins and glutathione-agarose. Many of the proteins that bound to the Src SH3 domain comigrated with proteins that bound to Fyn and Lyn SH3 domains (e. g., 200, 180, 170, 120, 100, 70, 65, and 55 kDa). However, several protein bands that bound to the Src and Lyn SH3 domains were not affinity purified with the Fyn SH3 domain (e.g., 140, 83, 80, and 73 kDa). In addition, the Lyn SH3 domain was found to bind to several proteins that were not detected among the Src and Fyn mutant domain (d190-92) containing a deletion of the highly conserved Y90-X-Y92 amino acids (lane 5), or Src' SH3 (60) .
Tyrosine phosphorylation of SH3-binding proteins. We previously showed that the Src SH3 domain specifically interacted with several tyrosine-phosphorylated proteins from SRD 3T3 cells (60) . Figure 3A shows an antiphosphotyrosine immunoblot of proteins affinity-purified from SRD 3T3 cells, using glutathione-agarose bound with equal amounts of either GST, GST-Src SH3, GST-Src SH3 (d190-92), GST-Src' SH3, GST- The specificity of the interaction between these tyrosinephosphorylated proteins and the Src SH3 domain was further examined by peptide competition experiments. The approach that we adopted was to use the Src-pro peptide (RSLRPLP-PLPPP), which was selected from a phage display library by using the Src SH3 domain (unpublished data), to selectively compete for proteins that interacted with the ligand binding site of the Src SH3 domain. Figure 3B shows an immunoblot from the competition assay probed with a MAb against phosphotyrosine. In this competition assay, SRD 3T3 cell lysates were incubated with glutathione-agarose bound with GST (lane 1) and GST-Src SH3 (0.7 ,uM; lanes 2 to 15) without peptide (lanes 2 and 3) or with increasing amounts of either the Src-pro peptide (lanes 4 to 7), the polyproline peptide (a mixture of proline homopolymer chains differing in the degree of polymerization; lanes 8 to 11), or an unrelated peptide (KGELRLRNYYYDVV; lanes 12 to 15). The Src-pro peptide blocked binding of the 62-, 130-, 160-, and 220-kDa tyrosinephosphorylated proteins to the Src SH3 domain. Although the polyproline peptide could also block the binding of 130-, 160-, and 220-kDa proteins to the Src SH3 domain, the concentration of the polyproline peptide required to exhibit similar degree of inhibition was more than eightfold higher than that of the Src-pro peptide (14 ,uM versus 112 ,uM; lane 5 versus lane 11; all estimations in the peptide competition assays were done by eye). An unrelated peptide did not block binding (lanes 12 to 15). A peptide derived from 3BP-1 (KGGAPT MPPPLPPVPPG) was also used in the competition experiment and was found to exhibit a degree of inhibition similar to that exhibited by the polyproline peptide (data not shown).
Identification of p62 as one of the Src SH3-binding proteins.
To identify cellular proteins that can bind to the Src SH3 in vitro, Src SH3-binding proteins from SRD 3T3 cells were purified by using a Src SH3 peptide affinity matrix (Affi-Gel 10). The same matrix was found to allow efficient isolation of SH3-binding proteins while maintaining specificity (60 GAP-associated protein p62 was indeed one of the SH3-binding proteins, we probed the immunoblot containing SH3-binding proteins with a polyclonal antibody against the GAPassociated protein p62 (Fig. 4A) . The Src, Fyn, and Lyn SH3 domains (lanes 3, 6, and 7) bound to a 62-kDa protein in SRD 3T3 cell lysates (lane 6) that is recognized by the anti-p62 antibody and which comigrated with the p62 detected in total cell lysates (lane 1). p62 bound most strongly to the Fyn SH3 domain (lane 6) and less strongly to the Lyn SH3 (lane 7) and the Src-SH3 (lane 3) domains and did not bind at all to GST alone (lane 2), Src SH3 (d190-92) (lane 4), or Src' SH3 (lanes 5). The specificity of the interaction between the Src SH3 domain and p62 was also examined with the Src-pro peptide (Fig. 4B) . The Src-pro peptide could block binding of the p62 to the Src SH3 domain, and 90% inhibition was seen at 7.0 pM (lane 6). The polyproline peptide (lanes 10 to 14) exhibited a similar degree of inhibition at an approximately eightfoldhigher concentration.
Identification of hnRNP K as one of the Src SH3-binding proteins. Since protein microsequencing data suggested that the major 62-kDa protein could also be hnRNP K and/or some related protein, we probed the blot containing the SH3-binding proteins with a MAb against hnRNP K (Fig. 5A) To eliminate the possibility of cross-reactivity of p62 and hnRNP K antibodies, we probed the hnRNP K immunoprecipitates with a p62 antibody. The lack of signal suggested that these two antibodies do not cross-react and recognize distinct proteins (data not shown). To examine whether binding of hnRNP K to GST-SH3 proteins was mediated through an unidentified pre-mRNA-binding protein, we reprobed the blot with an antibody to hnRNP Al, another highly abundant pre-mRNA-binding protein. hnRNP Al was not detected among the SH3-binding proteins (data not shown), suggesting that the hnRNP complex was not preserved under our binding conditions and supporting the possibility that hnRNP K is specifically associated with the relevant SH3 domains used in the binding assay.
Direct binding of cellular proteins, including hnRNP K, to the Src SH3 domain and analysis of the SH3-binding site in hnRNP K. To examine whether the SH3-binding proteins detected in the solution-binding assays could bind to the Src SH3 domain directly, we probed blots containing either a total cell lysate of SRD 3T3 cells or an hnRNP K immunoprecipitate from these cells with either GST alone (Fig. 6A) or the GST-Src SH3 fusion protein (Fig. 6B) . The bound GST proteins were detected with a MAb to GST. GST-Src SH3, but not GST, bound to a number of cellular proteins in total cell lysate (compare lanes 1 in Fig. 6A and B) and to the hnRNP K in the immunoprecipitate (compare lanes 4 in Fig. 6A and B) . Since there are several proline-rich stretches present in hnRNP K which could serve as potential SH3-binding sites, we examined whether these proline-rich sequences could bind to Src SH3 directly. Full-length hnRNP K, hnRNP K containing a deletion of the two proline-rich sequences between amino acids 284 and 320, or a fragment of hnRNP K containing only amino acids 284 to 320 was expressed as a GST fusion protein and transferred to nitrocellulose, and the filter was incubated with GST-Src SH3. The bound GST-Src SH3 was visualized with the Src SH3-specific MAb 327 (Fig. 6D) . GST-Src SH3 specifically bound to wild-type hnRNP K and hnRNP K (284-320) but not to hnRNP K (d1284-320), suggesting that amino acids 284 to 320 of hnRNP K are essential and sufficient polyacrylamide gel along with 0.5 jig of hnRNP K MAb only (lanes 3) or immunoprecipitates with a rabbit antibody against mouse immunoglobulin G (RotM; lanes 2). After incubation of the nitrocellulose blots with GST (A) or GST-Src SH3 (B), the bound GST proteins were detected by immunoblotting with the GST MAb. (C and D) GST-hnRNP K, GST-hnRNP K (d1284-320), or GST-hnRNP K (284-320) was transferred to nitrocellulose, and the filter was incubated with GST-Src SH3. The bound GST-Src SH3 was visualized by immunoblotting with the Src SH3-specific MAb 327 (D). A duplicate blot was probed with the hnRNP K MAb 3C2 (C). (E and F) The nitrocellulose filters immobilized with GST-SH3 fusion proteins were incubated with GST-hnRNP K (F) or GST-hnRNP K (d1284-320) (E). The bound hnRNP K proteins were then detected with the hnRNP K MAb 3C2.
antibody (Fig. 6C, lanes 2 and 3) . We also examined whether amino acids 284 to 320 of hnRNP K are required for its binding to the Fyn and Lyn SH3 domains. In this experiment, the nitrocellulose filters with immobilized GST-SH3 fusion proteins were incubated with GST-hnRNP K (d1284-320) (Fig.  6E) or GST-hnRNP K (Fig. 6F) . The bound hnRNP K proteins were then detected with the hnRNP K MAb 3C2. hnRNP K bound directly to the SH3 domains of Src, Fyn, and Lyn. hnRNP K (d1284-320) did not bind to the SH3 domains of Src, Fyn, and Lyn. Together, the data strongly suggest that hnRNP K binds directly to the SH3 domains of Src, Fyn, and Lyn and that the proline-rich motifs at amino acids 284 to 320 are sufficient and necessary for binding.
Identification of Shc as one of the Src, Fyn, and Lyn SH3-binding proteins. To identify other Src SH3-binding proteins, we analyzed the protein data base for other proteins containing contiguous proline-rich amino acid sequences. Shc, a signaling protein which is phosphorylated on tyrosine in v-Src-transformed cells, contains multiple proline-rich clusters.
To determine whether Shc can bind to the Src, Lyn, or Fyn SH3 domain, we probed blots containing proteins that bind to these domains with a polyclonal antiserum to Shc (Fig. 7A) .
Shc antiserum specifically recognized the p42, p52, and p66 forms of Shc (39) in the total cellular lysate from SRD 3T3 cells (lane 1). The p52 form of Shc was detected in the samples of the Src, Fyn, and Lyn SH3-binding proteins (lanes 3, 6, and 7); however, the p66 form of Shc was detectable only in the Fyn and Lyn SH3-binding proteins (lanes 6 and 7) . In an independent experiment, we also detected binding of the p46 form of Shc to the Lyn SH3 domain (data not shown). The specificity of binding of the p52 form of Shc to the Src SH3 domain was examined with the Src-pro and polyproline peptides (Fig. 7B) . The Src-pro peptide (lanes 5 to 9) inhibited binding of Shc to the Src SH3 domain, with 3.5 ,uM blocking approximately 80% of the binding (lane 5). The same degree of competition required the polyproline peptide at 28 ,uM (lanes 10 to 14) .
Tyrosine phosphorylation of SH3-and SH2-binding proteins in CEF expressing transforming variants of c-Src. The ability of the Src SH3 domain to bind to several tyrosinephosphorylated proteins in v-Src-transformed cells raised the question of whether the Src SH3 domain is required for substrate phosphorylation in vivo. To address this question, we examined the level of tyrosine phosphorylation of the Src SH3-binding proteins in cells expressing a mutant variant of Src containing a deletion of the SH3 domain. If the phosphorylation of these SH3-binding proteins were dependent on the Src SH3 in vivo, we would expect to see a reduction in tyrosine phosphorylation of these SH3-binding proteins in cells expressing the SH3 deletion mutant of Src. Chicken embryo fibroblasts (CEF) were infected with Rous sarcoma virus vectors encoding one of three activated variants of c-Src: E378G, dlA/E378G (SH3 deletion mutant; amino acids 88 to 137), or dlB/E378G (SH2 deletion mutant; amino acids 148 to 187). To specifically examine tyrosine phosphorylation of Src SH3-binding proteins, we compared the levels of tyrosine phosphorylation of proteins that bound to GST-Src SH3 in lysates of CEF (Fig. 8A, lanes 1 to 3) and CEF expressing E378G (lanes 4 to 6), dlA/E378G (lanes 7 to 9) or dlB/E378G (lanes 10 Fig. 8A with a polyclonal antibody against p62 (Fig. 8C) . Similar amounts of p62 were associated with the Src SH3 in CEF and in CEF expressing E378G, dlA/E378G, or dlB/E378G. Therefore, the reduction in the phosphorylation of this SH3-binding protein observed in CEF expressing dlA/E378G was not due to a reduction in its expression or its ability to bind to the Src SH3 domain.
For comparison, we performed a similar analysis of Src SH2-binding proteins (Fig. 8B) . The levels of tyrosine phosphorylation of the proteins that bound to Src SH2 in CEF expressing E378G and SH3 deletion mutant dlA/E378G were comparable. However, tyrosine phosphorylation of many of the proteins that bound to Src SH2 in CEF expressing the SH2 deletion mutant d1B/E378G was reduced significantly (Fig.  8B) . Interestingly, tyrosine phosphorylation of 50-to proteins that could bind to Src SH2 was elevated in cells expressing dlB/E378G. Since p62 and Shc have been reported to be tyrosine phosphorylated in Src-transformed cells, we directly analyzed tyrosine phosphorylation of p62 and Shc in CEF expressing E378G, dlA/E378G, or dlB/E378G (Fig. 9) . In these experiments, we immunoprecipitated Shc (Fig. 9A) and p62 (Fig. 9B) from the cell lysates and probed the blot containing the immunoprecipitates with a MAb against phosphotyrosine (4G10). Although the level of tyrosine phosphorylation of the p52 and p46 forms of Shc was not significantly reduced in CEF expressing dlA/E378G (Fig. 9A, lane 4) compared with that of Shc in CEF expressing E378G (lane 3) or dlB/E378G (lane 5), tyrosine phosphorylation of p62 was-virtually undetectable in CEF expressing dlA/E378G (Fig. 9B, lane 3) . Interestingly, tyrosine phosphorylation of p62 was also reduced by 80% in CEF expressing dlB/E378G (lane 4), suggesting a role for the SH2 domain for tyrosine phosphorylation or preserving tyrosine phosphorylation of the p62 in vivo. We were unable to detect tyrosine phosphorylation of hnRNP K in the Srctransformed SRD 3T3 cells (data not shown).
Association of Src protein with tyrosine-phosphorylated proteins in vivo. Several proteins have been reported to coprecipitate with v-Src from extracts of v-Src-transformed cells (18, 21) . The binding of one of these proteins (AFAP) is not detected in Src variants containing mutations in the SH3 domain (18) . To further analyze the involvement of the SH3 domain in the association of these proteins with Src, we examined the ability of the Src SH3-binding peptides to inhibit the coprecipitation of Src with other tyrosine-phosphorylated proteins (Fig. 10) . We also examined the ability of a highaffinity Src SH2-binding peptide (EPQpYEEIPI; here called YEEI) to block SH2 domain-dependent interactions. In this assay, BALB/c 3T3 and SRD 3T3 cells were lysed in RIPA buffer, and the Src protein was immunoprecipitated with a MAb to the amino terminus of Src in the presence or absence of the SH2-and SH3-binding peptides. For comparison, the SH3-binding proteins were also isolated by affinity purification with GST-Src SH3 (Fig. 10) . The samples were transferred to nitrocellulose, and the blot was probed with a MAb to phosphotyrosine. Two major tyrosine-phosphorylated proteins coprecipitated with v-Src from SRD 3T3 cells (Fig. 10A, lane 7) , one of which comigrated with the 62-kDa tyrosine-phosphorylated protein that bound to the Src SH3 domain; the other protein, with an Mr of 130,000, is most likely the 130,000-Da protein previously detected in v-Src immunoprecipitates (21) .
The binding of Src to the 62-kDa protein was reduced significantly by incubation of the extracts with the Src-pro peptide or the phosphorylated YEEI peptide but not the polyproline or the unphosphorylated YEEI peptide, suggesting that both the SH2 and SH3 domains of Src are required for stable association of this protein with Src. We have been unable to determine whether this protein is the p62 protein identified in the total cell SH3-binding proteins, since the p62 antibody is not sensitive enough to recognize the small amounts of the 62-kDa protein that associate with Src under these conditions. The Src-pro peptide and the pYEEI peptide could block only 50% of p130 binding to Src (Fig. 10B, lanes 5   and 7) , whereas 90% inhibition of p130 binding was observed when both peptides were used, suggesting that either the SH2 or the SH3 domain is sufficient for some degree of p130 association with Src. The evidence that Src, Fyn, and Lyn SH3 domains bind to a common set of proteins, as well as family member-specific binding proteins, suggests that the ligand binding domains of these SH3 domains have both common and distinct structural features. Analysis of the three-dimensional structure of Fyn and Src SH3 domains indicates that their structures are quite similar (35, 64) . An alignment of the amino acid sequence of the Lyn, Fyn, and Src SH3 domains is shown in Fig. 11 . The amino acids of Src SH3 that were perturbed in their 15N or 1HN chemical shifts following binding to the 3BP-1 prolinerich peptide (64) high-affinity peptide ligands remain to be determined, one could speculate that the conserved amino acids from the binding pockets of the Src, Fyn, and Lyn SH3 domains determine the core binding sites, whereas some of nonconserved residues contribute to the specificity of binding for each SH3 domain. In addition, on the basis of the structure of the Src SH3 domain, one would predict that the deletion of the Y-D-Y sequence in Src would disrupt binding to SH3 ligands since these two tyrosine residues comprise part of the hydrophobic binding pocket. Src' SH3 has an insert of six amino acids between residues Thr-114 and Glu-115, which also might affect protein binding because the insert is in the loop adjacent to the hydrophobic binding pocket (35, 64) . This possibility is consistent with the results that we obtained (Fig. 2 to 7) .
The identities of several Src, Lyn, and Fyn SH3-binding proteins were determined through analysis of the peptide sequence of affinity-purified proteins or through a search of the protein data base for proline-rich amino acid sequences. Peptide sequences from a 62-kDa Src SH3 ligand were closely related to peptides from hnRNP K and the GAP-associated protein p62. The identities of these molecules as Src, Fyn, and Lyn SH3-binding proteins were confirmed by using antibodies to hnRNP K or p62. We also identified dynamin as a Src SH3-binding protein through peptide sequence analysis of a 100,000-Da Src SH3-binding protein (data not shown). Dyn- 14, 1994 on January 11, 2018 by guest http://mcb.asm.org/ Downloaded from proteins was significantly reduced in cells expressing a Src SH3 deletion mutant but unaffected in cells expressing a wild-type activated variant or a Src SH2 deletion mutant. In addition, tyrosine phosphorylation of many of the SH2-binding proteins was diminished in cells expressing a Src SH2 deletion mutant but marginally affected in cells expressing the activated Src containing a Src SH3 deletion. These results raise the possibility that one role for the SH3 and SH2 domains of Src-like kinases is to bring potential substrates in close proximity to the catalytic domain. Previous studies on a v-Src substrate, AFAP, have also supported a role for the SH3 domain in determining the substrate selectivity (13) . Tyrosine phosphorylation of AFAP is deficient in cells expressing an SH3 deletion mutant but not an SH2 deletion mutant, and AFAP can bind to the Src SH3 domain in its unphosphorylated state. Thus, the SH3 domain of Src-like kinases could serve a function similar to that of the phosphotyrosine residues of receptor protein tyrosine kinases. For example, just as the pY-X-X-M motif on the platelet-derived growth factor receptor recruits phospholipase C--y to the receptor prior to tyrosine phosphorylation by the catalytic domain (22, 33) , binding of a protein such as AFAP or p62 to the SH3 domain of Src would bring these proteins into close approximation to Src's catalytic domain. Since many Src substrates were not affected by deletion of either SH3 or SH2, it is clear that recruitment by SH3 or SH2 is not the exclusive mechanism involved in substrate selection by Src.
These results, coupled with previous studies on the role of the Src SH3 domains in the localization of Src to focal adhesion sites, substrate binding and phosphorylation, and regulation of Src catalytic activity indicate that SH3 domains, like SH2 domains, can serve many functions through their intra-and intermolecular protein interactions. For Src-like kinases, these functions involve linking these kinases to downstream pathways through substrate recruitment to the catalytic domain, localizing these proteins to specific subcellular localization, and autoregulation of catalytic activity.
